Purba Dain
About Purba Dain
Purba Dain is a Supply Chain Manager at Kite Pharma, where she has worked since 2022. She has extensive experience in the medical devices sector, with a background in quality assurance, regulatory processes, and materials management.
Work at Kite Pharma
Purba Dain has been serving as a Supply Chain Manager at Kite Pharma since 2022. In this role, she is responsible for overseeing supply chain operations within the organization. Her expertise in materials management and regulatory experience in the medical devices sector contributes to her effectiveness in this position. Kite Pharma is known for its focus on innovative cancer therapies, and Dain's role is crucial in ensuring the efficient delivery of products.
Education and Expertise
Purba Dain holds multiple degrees in the life sciences. She earned a Master of Science in Biology from Indiana University of Pennsylvania, where she studied from 1997 to 2000. Additionally, she completed her undergraduate studies in Microbiology and Biophysics at the University of Mumbai, obtaining a Bachelor of Science and a Master of Science. Her educational background supports her expertise in quality control, validation processes, and supply chain management.
Background
Purba Dain has extensive experience in the medical and pharmaceutical sectors. She began her career at Siemens Medical Solutions, where she held various roles, including Technical Specialist and Data Analyst Level III. Over the years, she has worked for notable companies such as Baxter BioScience, Gilead Sciences, and Shire Pharmaceuticals, accumulating a diverse skill set that includes quality assurance and regulatory compliance.
Achievements
Throughout her career, Purba Dain has led projects focused on new design implementations in the medical devices field. Her regulatory experience includes validating new products and troubleshooting raw materials, which are essential for maintaining quality standards in the industry. Dain's contributions in quality assurance and supply chain management have been significant in her previous roles, particularly at Baxter BioScience and Gilead Sciences.